RCRitesh R. Chauhan

Ritesh R. Chauhan

*This is an algorithmically generated author record based on publicly available information.

Ritesh R. Chauhan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Bio Evaluation of Schiff Base and Their Metal Complexes: A Green Route to Potential Anticancer Agents

    by Krupa J. Thakkar, Rajesh J. Patel, Ritesh R. Chauhan, Priteshkumar M. Thakor, Jatin D. Patel, Hiteshkumar V. Patel, Anjali B. Thakkar, Jasmine A. Mansuri, Anju P. Kunjadiya

    The present study reports the successful synthesis and characterization of a new Schiff base ligand using a natural acid catalyst and its transition metal complexes. The synthesized ligand was comprehensively characterized using advanced physicochemical techniques, including liquid chromatography–mass spectrometry (LC–MS), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and 1H and 13C nuclear magnetic resonance (NMR) spectroscopy. Subsequently, these Schiff base was complexed with various transition metals to generate innovative metal complexes. The resulting complexes were further analyzed through IR spectroscopy, confirming coordination and structural features. In-vitro cytotoxicity studies demonstrated that the complexes showed strong anticancer activity against the A549 lung carcinoma cell line, with significantly higher inhibition than the ligand alone. Among the synthesized derivatives, compound 4b exhibited the strongest anticancer activity with the lowest IC50 value (84.71 μM). Antimicrobial evaluation further revealed broad-spectrum activity, particularly against Gram-negative bacteria. Among all tested derivatives, compound 4i demonstrated the highest antibacterial activity, showing the largest zones of inhibition across multiple bacterial strains compared to the other compounds. In-silico docking analysis supported these experimental findings by indicating favorable binding interactions and drug-likeness profiles. Based on the DFT results, compound 4b exhibited the highest HOMO–LUMO energy gap (ΔE = 8.75 eV) and the lowest IC50 (IC50 = 84.71 μM) value, indicating superior molecular stability and the strongest biological activity among the tested derivatives. Overall, the study establishes that Schiff base–metal complexes possess superior anticancer and antimicrobial potential, highlighting them as promising scaffolds for future therapeutic development.


  • Open Access

    Novel Functional Acrylic Copolymers: Synthesis, Characterization, Molecular Docking and Biological Efficacy

    by Rajesh J. Patel, Bindu C. Patel, Akash K. Patel, Ritesh R. Chauhan, Zarna R. Patel, Jatin D. Patel, Pritesh M. Thakor, Keyur M. Pandya, Chirag R. Patel

    In this study, the functional methacrylate monomers 2,4-dichlorophenyl methacrylate (2,4-DMA) and vanillin methacrylate (VMA) were synthesized and subjected to free-radical (co)polymerization at controlled feed ratios to generate a compositionally tunable copolymer series. Monomer-to-polymer conversion and chain microstructure were verified using FT-IR, 1H NMR and HPLC. The disappearance of vinyl proton resonances and the loss of C=C stretching bands, combined with high chromatographic purity (>99%), confirmed efficient propagation and minimal side reactions. Compositional variations in the copolymers were further reflected in systematic shifts in carbonyl and aromatic vibrational domains, consistent with differing contributions of the 2,4-dichlorophenyl and vanillin units to the polymer backbone. Biological evaluation demonstrated a clear composition-dependent antimicrobial response, with 2,4-DMA-rich copolymers exhibiting the highest inhibition against both bacterial and fungal strains. To complement the experimental findings, a molecular docking analysis was also performed against E. coli DNA gyrase (PDB: 1KZN). The selected copolymer fragment displayed a binding affinity of –5.20 kcal/mol, supported by hydrogen bonding with ASN46 and stabilizing π-alkyl, π-sigma, and alkyl interactions with residues such as ALA47, THR165, VAL43 and VAL167, consistent with the observed antibacterial potency. Based on the results, this study establishes 2,4-DMA/VMA copolymers as a structurally adaptable platform with tunable antimicrobial performance enhanced by favorable protein-binding interactions. These materials show promising aspects for antimicrobial coatings, protective films and biologically responsive polymer systems.